Back to BBIO
Janus Henderson Group Ltd. → BBIO
Janus Henderson Group Ltd. BBIO Position History
BridgeBio Pharma, Inc. • Healthcare
Quarters held
20
Latest value
$8.4M
Q3 2026
Peak value
$950.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $15.5M |
| Q4 2025 | $817.5M |
| Q4 2025 | $6.8M |
| Q4 2025 | $1.4M |
| Q4 2025 | $191K |
| Q1 2026 | $252K |
| Q1 2026 | $950.9M |
| Q1 2026 | $16.8M |
| Q1 2026 | $1.4M |
| Q1 2026 | $9.3M |
| Q1 2026 | $252K |
| Q1 2026 | $16.8M |
| Q1 2026 | $950.9M |
| Q1 2026 | $1.4M |
| Q1 2026 | $9.3M |
| Q3 2026 | $930.9M |
| Q3 2026 | $202K |
| Q3 2026 | $1.2M |
| Q3 2026 | $17M |
| Q3 2026 | $8.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $8.4M | 128.3K | — | — |
| Q3 2026 | $17M | 258.0K | — | — |
| Q3 2026 | $1.2M | 18.2K | — | — |
| Q3 2026 | $202K | 3.1K | — | — |
| Q3 2026 | $930.9M | 14.15M | — | — |
| Q1 2026 | $9.3M | 124.7K | — | — |
| Q1 2026 | $1.4M | 18.6K | — | — |
| Q1 2026 | $950.9M | 12.81M | — | — |
| Q1 2026 | $16.8M | 226.9K | — | — |
| Q1 2026 | $252K | 3.4K | — | — |
| Q1 2026 | $9.3M | 124.7K | — | — |
| Q1 2026 | $1.4M | 18.6K | — | — |
| Q1 2026 | $16.8M | 226.9K | — | — |
| Q1 2026 | $950.9M | 12.81M | — | — |
| Q1 2026 | $252K | 3.4K | — | — |
| Q4 2025 | $191K | 2.5K | — | — |
| Q4 2025 | $1.4M | 18.9K | — | — |
| Q4 2025 | $6.8M | 88.3K | — | — |
| Q4 2025 | $817.5M | 10.69M | — | — |
| Q4 2025 | $15.5M | 202.2K | — | — |
Other funds holding BBIO
$879.4M